Valuation: ResMed, Inc.

Market Cap 2.78TCr 2.43TCr 2.25TCr 2.08TCr 3.91TCr 2,67400Cr 3.98TCr 27TCr 11TCr 1,30900Cr 10TCr 10TCr 4,50900Cr P/E 2026 *
18.2x
P/E 2027 * 16.3x
Enterprise Value 2.7TCr 2.36TCr 2.18TCr 2.02TCr 3.8TCr 2,59700Cr 3.87TCr 26TCr 10TCr 1,27200Cr 10TCr 9.93TCr 4,37800Cr EV / Sales 2026 *
4.78x
EV / Sales 2027 * 4.36x
Free-Float
75.61%
Yield 2026 *
1.26%
Yield 2027 * 1.36%
1 day-2.77%
1 week-12.17%
Current month-0.96%
1 month-0.91%
3 months-16.33%
6 months-25.63%
Current year-19.87%
1 week 190.25
Extreme 190.25
209.36
1 month 184.65
Extreme 184.65
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/07Fiscal year

Chief Executive Officer

14,973 0.0103%
08/06Fiscal year

Chief Executive Officer

14,973 0.0103%
01/06Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-2.77%-12.17%-24.04%-13.20% 2.78TCr
+1.05%+3.38%+25.56%+0.89% 20TCr
-6.78%-11.19%-26.52%+7.20% 13TCr
-0.55%+2.50%+0.66%-17.25% 14TCr
-4.52%-5.89%-59.14%-19.61% 6.34TCr
-1.85%-4.99%+15.09%-3.52% 5.19TCr
-0.22%-2.72%-25.44%-33.65% 4.38TCr
+0.87%+3.10%+12.59%+12.90% 3.82TCr
+0.85%+0.39%+23.74%+39.01% 3.7TCr
-5.59%-4.98%-17.18%-24.64% 2.8TCr
Average -1.39%-2.74%-7.47%-5.19% 7.64TCr
Weighted average by Cap. -1.29%-1.45%-2.97%-4.33%

Financials

2026 *2027 *
Net sales 565.02Cr 493.77Cr 456.45Cr 421.71Cr 794.15Cr 54TCr 808.54Cr 5.44TCr 2.14TCr 27TCr 2.12TCr 2.08TCr 92TCr 606.95Cr 530.42Cr 490.33Cr 453.01Cr 853.1Cr 58TCr 868.55Cr 5.85TCr 2.29TCr 29TCr 2.28TCr 2.23TCr 98TCr
Net income 154.8Cr 135.28Cr 125.05Cr 115.54Cr 217.57Cr 15TCr 221.51Cr 1.49TCr 585.11Cr 7.28TCr 581.45Cr 568.6Cr 25TCr 170.74Cr 149.21Cr 137.93Cr 127.44Cr 239.98Cr 16TCr 244.33Cr 1.64TCr 645.38Cr 8.03TCr 641.33Cr 627.16Cr 28TCr
Net Debt -80Cr -70Cr -65Cr -60Cr -112.98Cr -7.72TCr -115.03Cr -774.44Cr -303.85Cr -3.78TCr -301.94Cr -295.27Cr -13TCr -136.04Cr -118.89Cr -109.9Cr -101.54Cr -191.21Cr -13TCr -194.68Cr -1.31TCr -514.23Cr -6.4TCr -511Cr -499.71Cr -22TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
14/26/14 $193.01 -2.77% 16,22,359
13/26/13 $198.50 -2.63% 21,61,420
10/26/10 $203.87 -2.20% 13,31,149
09/26/09 $208.45 +1.27% 14,79,036
08/26/08 $205.84 -6.33% 17,61,755
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
193.01USD
Average target price
253.20USD
Spread / Average Target
+31.18%

Quarterly revenue - Rate of surprise